Skip to main
IMAX

IMAX (IMAX) Stock Forecast & Price Target

IMAX (IMAX) Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 40%
Buy 50%
Hold 10%
Sell 0%
Strong Sell 0%

Bulls say

Imax Corp has reported impressive financial growth, with full-year revenue increasing by 16.5% year-over-year and adjusted EBITDA reaching $184.9 million, reflecting a robust margin of 45.1%, which is a significant improvement of 570 basis points year-over-year. The company's global box office performance demonstrated remarkable strength, achieving a record $1.28 billion in 2025, up approximately 40% year-over-year, while the North American and Chinese markets also showed substantial growth with increases of 23% and 138% respectively. Furthermore, the expansion of consolidated gross margins to 57.6% from 52.2% the previous year, particularly within Content Solutions, underscores the effectiveness of Imax's business model and proprietary technology in driving profitability.

Bears say

Imax Corp's recent financial performance indicates a concerning trend, as the company's backlog decreased from 440 to 434, suggesting a potential slowdown in its business operations. Additionally, the revised Q4 revenue forecast of $120.5 million, down from the previous estimate of $122.3 million, highlights the impact of lower box office performance compared to prior years. Moreover, challenges in the exhibition industry, exacerbated by the effects of COVID-19, continue to pressure Imax's financial health despite its positioning in top-performing complexes.

IMAX (IMAX) has been analyzed by 10 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 50% recommend Buy, 10% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IMAX and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IMAX (IMAX) Forecast

Analysts have given IMAX (IMAX) a Buy based on their latest research and market trends.

According to 10 analysts, IMAX (IMAX) has a Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $44.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $44.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IMAX (IMAX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.